StockData
Protagonist Therapeutics, Inc logo

Protagonist Therapeutics, Inc (PTGX) shareholders

PTGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/30199% above fair value
$124.67−0.16 (-0.13%)

Close on Nov 17, 2026Market cap $8.07BP/E 121.0Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
100.0%
76M of 65M shares
Institutional holders
343
63 new, 36 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 37 sales
Net sold $95.33M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
BlackRock, Inc.9,834,14615.20%13G (passive) amendmentSep 30, 2026
Wehrly, Mark C.
Joint filing with Farallon Capital Management, L.L.C. (9.99%), Dapice Joshua J. (9.99%) and 13 more
6,433,1199.99%13G (passive) amendmentJun 30, 2026
Saito Edric C.
Joint filing with Wehrly, Mark C. (9.99%), Short Daniel S. (9.99%) and 15 more
6,248,0139.99%13G (passive) amendmentDec 31, 2025
Patel, Rajiv A.
Joint filing with Wehrly, Mark C. (9.99%), Short Daniel S. (9.99%) and 17 more
5,956,4889.99%13G (passive) amendmentDec 31, 2024
Roderick Wong
Joint filing with RTW Investments, LP (8.10%)
5,059,0538.10%13G (passive) amendmentDec 31, 2025
Vanguard Portfolio Management3,533,0155.53%13G (passive)Mar 31, 2026
State Street Corporation3,321,5545.20%13G (passive)Jun 30, 2026
Vanguard Capital Management3,250,0035.09%13G (passive)Mar 31, 2026
David Kroin
Joint filing with Deep Track Capital, LP (5.29%), Deep Track Biotechnology Master Fund, Ltd. (5.29%)
3,250,0005.29%13G (passive)Apr 3, 2025
Wellington Investment Advisors Holdings LLP
Joint filing with Wellington Management Group LLP (5.10%), Wellington Group Holdings LLP (5.10%)
3,171,4235.10%13G (passive)Dec 31, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of PTGXValueChange% of portfolio
BlackRock, Inc.10,307,83715.93%$1.26B+528,4680.02%
Farallon Capital Management LLC6,348,9069.81%$778.25M–3.59%
Rtw Investments, LP5,061,1757.82%$620.40M+2,1225.30%
Vanguard Portfolio Management LLC3,629,2985.61%$444.88M+148,0870.02%
Wellington Management Group Llp3,416,7815.28%$418.83M−182,8630.07%
UBS Group AG3,399,2215.25%$416.68M−1,778,5750.05%
State Street Corp3,321,5545.13%$407.16M+204,8050.01%
Vanguard Capital Management LLC2,853,3944.41%$349.77M+47,4980.01%
Johnson & Johnson2,449,1833.78%$300.22M–37.59%
Invesco Ltd.2,340,6673.62%$286.92M+175,9970.02%
Price T Rowe Associates Inc /Md/2,149,6623.32%$263.51M+484,1650.03%
Jupiter Topco LLC2,129,7803.29%$261.04MNew0.11%
Geode Capital Management, LLC1,741,2092.69%$213.48M+71,8380.01%
Woodline Partners LP1,414,1732.19%$173.35M–0.54%
Bank Of America Corp /De/1,324,4982.05%$162.36M+29,0640.01%
Jennison Associates LLC1,151,6811.78%$141.17M+79,6700.08%
Perceptive Advisors LLC981,8791.52%$120.36M−249,0001.81%
ADAR1 Capital Management, LLC960,8631.48%$117.78M−33,2565.39%
Morgan Stanley905,9921.40%$111.06M−112,2300.01%
Alyeska Investment Group, L.P.889,2981.37%$109.01M+296,1010.28%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202634376M100.0%63 / 14088 / 367M8M
Q1 202632079M100.0%60 / 110103 / 4918M4M
Q4 202531671M100.0%84 / 97103 / 3912M12M
Q3 202527571M100.0%42 / 85108 / 387M7M
Q2 202527371M100.0%51 / 11977 / 4911M6M
Q1 202527565M100.0%72 / 8492 / 3410M8M
Q4 202424164M98.6%45 / 9176 / 417M6M
Q3 202424062M96.3%79 / 7764 / 2421M12M
Q2 202418859M91.9%30 / 6368 / 267M12M
Q1 202418564M98.9%49 / 6256 / 2013M8M
Q4 202315659M91.4%32 / 4060 / 1911M9M
Q3 202314457M87.7%17 / 6640 / 4010M10M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

393 funds held PTGX in Q2 2026, 53% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of PTGXValue% of fundAs of
iShares Core S&P Small-Cap ETF3,641,8245.63%$446.41M0.40%Jun 30, 2026
Vanguard Total Stock Market Index Fund2,044,9383.16%$250.67M0.01%Jun 30, 2026
iShares Russell 2000 ETF1,579,8492.44%$193.66M0.23%Jun 30, 2026
Vanguard Small-Cap Index Fund1,475,4222.28%$180.86M0.10%Jun 30, 2026
Vanguard Health Care Fund1,243,6181.92%$169.93M0.45%Jul 31, 2026
State Street(R) SPDR(R) S&P(R) Biotech ETF941,3671.45%$115.39M1.07%Jun 30, 2026
Vanguard Explorer Fund881,1561.36%$120.40M0.54%Jul 31, 2026
Vanguard Small-Cap Growth Index Fund849,9021.31%$104.18M0.22%Jun 30, 2026
T. Rowe Price Health Sciences Fund, Inc.828,5591.28%$101.56M0.85%Jun 30, 2026
Invesco Discovery Fund810,0871.25%$80.65M1.03%May 31, 2026
Vanguard Extended Market Index Fund693,4661.07%$85.01M0.09%Jun 30, 2026
Fidelity Small Cap Index Fund672,6591.04%$91.91M0.27%Jul 31, 2026
Select Biotechnology Portfolio607,7130.94%$60.50M1.15%May 31, 2026
Invesco S&P SmallCap Momentum ETF569,7780.88%$77.85M2.57%Jul 31, 2026
iShares Russell 2000 Growth ETF568,1740.88%$69.65M0.45%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Dinesh V. Ph D. PatelPresident and CEO, Director522,9680.81%Sep 10, 2026
Arturo Molina MdChief Medical Officer81,3970.13%Nov 17, 2026
Asif AliChief Financial Officer59,0030.09%Oct 2, 2026
Suneel GuptaChief Development Officer267,4330.41%Nov 27, 2024
William D. WaddillDirector7,8250.01%Jun 25, 2026
Bryan GiraudoDirector12,6950.02%May 11, 2026
Harold E. SelickDirector84,8450.13%Mar 27, 2026
Lewis T. WilliamsDirector7,8250.01%Feb 18, 2026
Sarah A. O'DowdDirector7,8250.01%Jan 6, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Arturo Molina Md
Chief Medical Officer
Nov 16, 2026Sale−2,718$124.65$338.80K81,397
Asif Ali
Chief Financial Officer
Sep 30, 2026Sale(10b5-1 plan)−46,034$141.78$6.53M59,003
Asif Ali
Chief Financial Officer
Sep 30, 2026Sale(10b5-1 plan)−12,595$141.77$1.79M105,037
Asif Ali
Chief Financial Officer
Sep 30, 2026Option exercise+5,312$12.17$64.65K117,632
Asif Ali
Chief Financial Officer
Sep 30, 2026Option exercise+15,650$19.19$300.32K112,320
Asif Ali
Chief Financial Officer
Sep 30, 2026Option exercise+28,438$23.42$666.02K96,670
Asif Ali
Chief Financial Officer
Sep 30, 2026Option exercise+9,229$38.98$359.75K68,232
Dinesh V. Ph D. Patel
President and CEO, Director
Sep 10, 2026Sale(10b5-1 plan)−7,278$144.10$1.05M522,968
Dinesh V. Ph D. Patel
President and CEO, Director
Sep 10, 2026Option exercise+7,278$21.58$157.06K530,246
Dinesh V. Ph D. Patel
President and CEO, Director
Sep 9, 2026Option exercise+63,548$21.58$1.37M586,516
Dinesh V. Ph D. Patel
President and CEO, Director
Sep 9, 2026Sale(10b5-1 plan)−63,548$146.18$9.29M522,968
Dinesh V. Ph D. Patel
President and CEO, Director
Sep 8, 2026Option exercise+54,174$21.58$1.17M577,142
Dinesh V. Ph D. Patel
President and CEO, Director
Sep 8, 2026Sale(10b5-1 plan)−54,174$145.87$7.90M522,968
Dinesh V. Ph D. Patel
President and CEO, Director
Sep 3, 2026Gift−510––522,968
Dinesh V. Ph D. Patel
President and CEO, Director
Aug 11, 2026Option exercise+34,239$21.58$738.88K557,717
Dinesh V. Ph D. Patel
President and CEO, Director
Aug 11, 2026Sale(10b5-1 plan)−34,239$148.52$5.09M523,478
Dinesh V. Ph D. Patel
President and CEO, Director
Aug 10, 2026Sale(10b5-1 plan)−65,761$149.11$9.81M523,478
Dinesh V. Ph D. Patel
President and CEO, Director
Aug 10, 2026Option exercise+65,761$21.58$1.42M589,239
William D. Waddill
Director
Jun 23, 2026Sale(10b5-1 plan)−9,000$117.94$1.06M7,825
William D. Waddill
Director
Jun 23, 2026Option exercise+9,000$16.54$148.86K16,825
William D. Waddill
Director
Jun 10, 2026Option exercise+6,000$16.54$99.24K16,825
William D. Waddill
Director
Jun 10, 2026Sale(10b5-1 plan)−9,000$107.68$969.12K7,825
William D. Waddill
Director
Jun 10, 2026Option exercise+3,000$11.80$35.40K10,825
William D. Waddill
Director
May 29, 2026Option exercise+9,000$11.80$106.20K16,825
William D. Waddill
Director
May 29, 2026Sale(10b5-1 plan)−9,000$99.64$896.76K7,825
Dinesh V. Ph D. Patel
President and CEO, Director
May 12, 2026Option exercise+75,000$21.58$1.62M598,478
Dinesh V. Ph D. Patel
President and CEO, Director
May 12, 2026Sale(10b5-1 plan)−75,000$100.12$7.51M523,478
Dinesh V. Ph D. Patel
President and CEO, Director
May 12, 2026Sale−75,000$100.12$7.51M523,478
Dinesh V. Ph D. Patel
President and CEO, Director
May 12, 2026Option exercise+75,000$21.58$1.62M598,478
Bryan Giraudo
Director
May 8, 2026Sale−6,000$100.00$600.00K0
Bryan Giraudo
Director
May 8, 2026Sale−5,130$100.00$513.00K12,695
Bryan Giraudo
Director
May 7, 2026Sale−12,000$100.07$1.20M6,000
Bryan Giraudo
Director
May 7, 2026Sale−36,000$100.14$3.61M27,825
Bryan Giraudo
Director
May 7, 2026Option exercise+12,000$6.98$83.76K43,825
Bryan Giraudo
Director
May 7, 2026Option exercise+24,000$6.45$154.80K31,825
Dinesh V. Ph D. Patel
President and CEO, Director
Apr 23, 2026Gift−1,460––523,478
Asif Ali
Chief Financial Officer
Apr 20, 2026Sale−1,750$105.47$184.57K59,003
Harold E. Selick
Director
Mar 26, 2026Option exercise+24,000$12.88$309.12K84,845
Harold E. Selick
Director
Mar 26, 2026Sale−24,000$105.00$2.52M60,845
Arturo Molina Md
Chief Medical Officer
Mar 26, 2026Option exercise+15,000$8.04$120.60K99,115
Arturo Molina Md
Chief Medical Officer
Mar 26, 2026Sale−15,000$104.79$1.57M84,115
Asif Ali
Chief Financial Officer
Mar 26, 2026Option exercise+19,500$19.19$374.21K80,253
Asif Ali
Chief Financial Officer
Mar 26, 2026Option exercise+5,265$12.17$64.08K85,518
Asif Ali
Chief Financial Officer
Mar 26, 2026Sale−24,765$104.24$2.58M60,753
Dinesh V. Ph D. Patel
President and CEO, Director
Mar 25, 2026Option exercise+54,641$8.58$468.82K579,579
Dinesh V. Ph D. Patel
President and CEO, Director
Mar 25, 2026Sale−54,641$101.00$5.52M524,938
Dinesh V. Ph D. Patel
President and CEO, Director
Mar 24, 2026Sale−59$101.00$5.96K524,938
Dinesh V. Ph D. Patel
President and CEO, Director
Mar 24, 2026Option exercise+59$8.58$506524,997
Dinesh V. Ph D. Patel
President and CEO, Director
Mar 23, 2026Gift−50,000––524,938
Lewis T. Williams
Director
Feb 17, 2026Sale−18,000$82.42$1.48M7,825
Lewis T. Williams
Director
Feb 17, 2026Option exercise+18,000$10.84$195.12K25,825
William D. Waddill
Director
Feb 6, 2026Sale−20,000$83.68$1.67M7,825
William D. Waddill
Director
Feb 6, 2026Option exercise+20,000$8.31$166.20K27,825
Dinesh V. Ph D. Patel
President and CEO, Director
Jan 27, 2026Option exercise+4,068$21.58$87.79K578,573
Dinesh V. Ph D. Patel
President and CEO, Director
Jan 27, 2026Sale−4,068$83.19$338.42K574,505
Arturo Molina Md
Chief Medical Officer
Jan 27, 2026Option exercise+5,000$8.04$40.20K89,115
Arturo Molina Md
Chief Medical Officer
Jan 27, 2026Sale−5,000$82.00$410.00K84,115
Asif Ali
Chief Financial Officer
Jan 27, 2026Sale−18,203$83.14$1.51M60,320
Asif Ali
Chief Financial Officer
Jan 27, 2026Sale−28,000$83.13$2.33M78,523
Asif Ali
Chief Financial Officer
Jan 27, 2026Option exercise+16,000$19.19$307.04K94,523

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
16.09%
10M shares short
Days to cover
16.9
At 1M shares a day
Change since last report
-0.5%
From 10M shares
Short volume, 20 days
62.6%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Protagonist Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 53,618 shares on Oct 1, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Asif Ali
Officer
Sep 30, 202658,629$8.26MSep 30, 2026Exercise of Stock Options
Dinesh V. Ph D. Patel
CEO
Aug 10, 2026225,000$33.58MAug 10, 2026Option Exercise
William D. Waddill
Director
Jun 23, 20269,000$1.04MJun 23, 2026Exercise of Stock Options
William D. Waddill
Director
Jun 10, 20269,000$952.83KJun 10, 2026Exercise of Stock Options
William D. Waddill
Director
May 29, 20269,000$903.69KMay 29, 2026Exercise of Stock Options
Dinesh V. Ph D. Patel
CEO
May 12, 202675,000$7.76MMay 12, 2026Option Exercise
Bryan M & Courtney L Giraudo Rt
Director
May 8, 202611,130$1.11MMay 8, 2026Compensation
Bryan Giraudo
Director
May 7, 202636,000$3.60MMay 7, 2026Stock Option Exercise
Bryan M & Courtney L Giraudo Rt
Director
May 7, 202612,000$1.20MMay 7, 2026Compensation
Asif Ali
Officer
Apr 21, 20261,750$184.57KApr 20, 2026Restricted stock vesting under a registered plan
Harold E. Selick
Director
Mar 26, 202624,000$2.52MMar 26, 2026Stock Option Exercise
Arturo Molina Md
Officer
Mar 26, 202615,000$1.57MMar 26, 2026Stock Option Exercise
Asif Ali
Officer
Mar 26, 202624,765$2.58MMar 26, 2026Stock Option Exercise
Dinesh V. Ph D. Patel
CEO
Mar 24, 202654,700$5.39MMar 24, 2026Option Exercise
Lewis T. Williams
Director
Feb 17, 202618,000$1.48MFeb 17, 2026Stock Option Exercise

See a number that looks wrong?